Print

Print


The "(see box)" comment in this post of the first half of the JHMI
article refers to the info in my "JHMI PD #2" post.
 
Source: Page 6 of the December 1995 issue of "Health After 50",
by the John Hopkins Medical Institute of Baltimore, MD.
 
Parkinson's Disease: When to Consider Surgery
 
Surgery for Parkinson's disease is a favorite media topic that
periodically raises hope for the one out of every 100 Americans
over age 60 who live with the tremor, muscle stiffness, slow
movement, and impaired balance caused by this common
neurological disorder.
 
Drug therapy can usually provide relief for 10 to 15 years. Its
linchpin is levodopa (also called L-dopa), a medication with a
chemical formula similar to dopamine (a chemical messenger
produced in the brain). When L-dopa reaches the brain, it's
converted into dopamine and used to control movement. But
L-dopa therapy often causes nausea, and exentually leads to
involuntary arm and leg movements (dyskinesia) and to frequent
and dramatic fluctuations in symptoms. These side effects can be
limited by taking L-dopa with other drugs, such as carbidopa (sold
together with levodopa as Sinemet). Other important treatment
measures include exercise to help maintain strength and dexterity,
and sometimes dietary changes because certain amino acids
found in proteins can hinder the absorption of L-dopa.
 
SURGICAL OPTIONS
 
Surgery, once a mainstay of treatment, was abandoned in the
1960s, when L-dopa therapy was introduced. However, improved
techniques, as well as the limitations of drug treatment, have
prompted a return to the operating theater. Of the three
procedures available, the two most established--thalamotomy and
pallidotomy--require the destruction of certain brain cells that
interfere with normal movement. These cells can be identified by
using electricity to stimulate various areas of the brain (a
procedure called brain mapping). The technique is also used to
identify cells that control sight and other senses, so that they
won't be inadvertently destroyed during surgery.
 
Candidates must be relatively young (usually under age 65 or 70),
in otherwise good health, and have the specific symptoms a
particular technique is designed to address (see box). When
appropriate, surgery often relieves symptoms and decreases the
need for medication, but it's not a cure--nor does it stop
progression.
 
If you're considering surgery, choose an institution that has been
involved in research and specializes in the procedure you want. It
should provide you with a neurologist who specializes in
Parkinson's, and a neurosurgeon experienced in the procedure.
Four of the most-active centers are: The University of Colorado at
Denver (303-270-6927); New York's Columbia University
(212-305-5779); Johns Hopkins (410-955-8795); and Emory
University in Atlanta (404-727-4085). Colorado and Columbia are
recruiting patients for a fetal tissue transplantation study funded
by the National Institutes of Health. Johns Hopkins and Emory are
known for their work in thalamotomy and pallidotomy. Other
prominent centers include New York University Medical Center,
Baylor College of Medicine in Houston, The Mayo Clinic in
Rochester, MN, and Loma Linda University Medical Center in
Loma Linda, CA.